BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3095985)

  • 1. [Biochemical diagnosis of Anderson-Fabry disease in two brothers].
    Vidershaĭn GIa; Beĭer EM; Mendel'son MM; Livandovskiĭ IuA
    Vopr Med Khim; 1986; 32(5):120-3. PubMed ID: 3095985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pseudo-clinical Fabry's disease without alpha galactosidase deficiency.
    Peltier A; Herbeuval E; Brondeau MT; Belleville F; Nabet P
    Biomedicine; 1977 May; 26(3):194-201. PubMed ID: 407951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pseudodeficiency of alpha-galactosidase A.
    Bach G; Rosenmann E; Karni A; Cohen T
    Clin Genet; 1982 Jan; 21(1):59-64. PubMed ID: 6279339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterozygote detection in Fabry disease utilizing multiple enzyme activities.
    Sheth KJ; Good TA; Murphy JV
    Am J Med Genet; 1981; 10(2):141-6. PubMed ID: 6274191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diagnosis of Fabry's disease].
    Mendel'son MM; Livandovskiĭ IuA; Vidershaĭn GIa; Bruk EI; Il'ina GS
    Ter Arkh; 1987; 59(8):137-41. PubMed ID: 3120344
    [No Abstract]   [Full Text] [Related]  

  • 6. [Biochemical study of unusual cases of Fabry disease].
    Beĭer EM; Karpova EA; Udalova OV; Tsvetkova IV
    Vopr Med Khim; 1998; 44(5):494-500. PubMed ID: 9916266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Substrate specificity of multiple forms of human alpha-D-galactosidase and alpha-D-fucosidase].
    Baskaeva EM; Shono NI; Kozlova IK; Vidershaĭn GIa
    Biokhimiia; 1989 Mar; 54(3):421-6. PubMed ID: 2546612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Angiokeratoma corporis diffusum (Fabry's disease). Update. Apropos of 2 cases].
    Larralde de Luna M; García Díaz R; Sánchez G; Ilari R; Pierini AM; Campoy C; Chamoles NH
    Med Cutan Ibero Lat Am; 1985; 13(2):129-40. PubMed ID: 2995736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fabry disease: an ultrastructural comparative study of skin in hemizygous and heterozygous patients.
    Navarro C; Teijeira S; Dominguez C; Fernandez JM; Rivas E; Fachal C; Barrera S; Rodriguez C; Iranzo P
    Acta Neuropathol; 2006 Feb; 111(2):178-85. PubMed ID: 16463201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The neurological complications of Anderson-Fabry disease (alpha-galactosidase A deficiency)--investigation of symptomatic and presymptomatic patients.
    Morgan SH; Rudge P; Smith SJ; Bronstein AM; Kendall BE; Holly E; Young EP; Crawfurd MD; Bannister R
    Q J Med; 1990 May; 75(277):491-507. PubMed ID: 2167495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Molecular forms of human leukocytic alpha-galactosidase and N-acetyl-alpha-galactosaminidase].
    Salvayre R; Maret A; Nègre A; Douste-Blazy L
    C R Seances Acad Sci D; 1979 Mar; 288(12):995-8. PubMed ID: 223774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Manifestation of angiokeratoma diffusum in a girl patient with heterozygous genotype for Fabry disease.
    László A; Török L; Havass Z; Bartos Z
    Acta Paediatr Hung; 1988-1989; 29(3-4):331-6. PubMed ID: 3151983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anderson-Fabry disease: a case-finding study among male kidney transplant recipients in Austria.
    Kleinert J; Kotanko P; Spada M; Pagliardini S; Paschke E; Paul K; Voigtländer T; Wallner M; Kramar R; Stummvoll HK; Schwarz C; Horn S; Holzer H; Födinger M; Sunder-Plassmann G
    Transpl Int; 2009 Mar; 22(3):287-92. PubMed ID: 18954370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disease manifestations and X inactivation in heterozygous females with Fabry disease.
    Maier EM; Osterrieder S; Whybra C; Ries M; Gal A; Beck M; Roscher AA; Muntau AC
    Acta Paediatr Suppl; 2006 Apr; 95(451):30-8. PubMed ID: 16720462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Fabry disease: clinic and enzymatic diagnosis of homozygous and heterozygous. New therapeutic prospects].
    Peces R; Olea T
    Nefrologia; 2002; 22(6):540-6. PubMed ID: 12516287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diagnosis of Fabry's disease].
    Ulmann A; Lenoir G; Baumann N; Grünfeld JP
    Nouv Presse Med; 1976 Nov; 5(40):2697-700. PubMed ID: 826883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical, histopathological, and biochemical findings in Fabry's disease. A case report and family study.
    Savi M; Olivetti G; Neri TM; Curtoni C
    Arch Pathol Lab Med; 1977 Oct; 101(10):536-9. PubMed ID: 199133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Enzyme diagnostics in lysosomal diseases with emphasis on sphingolipidoses].
    Dreyfus JC; Poenaru L
    Arch Fr Pediatr; 1975; 32(6):503-14. PubMed ID: 810108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trihexosylceramide alpha-galactosidase of human leucocytes.
    Poulos A; Beckman K
    Clin Chim Acta; 1978 Oct; 89(1):35-45. PubMed ID: 101320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enzyme therapy XVII: metabolic and immunologic evaluation of alpha- galactosidase A replacement in Fabry disease.
    Desnick RJ; Dean KJ; Grabowski GA; Bishop DF; Sweeley CC
    Birth Defects Orig Artic Ser; 1980; 16(1):393-413. PubMed ID: 6256019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.